Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial.
Ferreri
A J M
AJ
Ponzoni
M
M
Dognini
G P
GP
Du
M-Q
MQ
Doglioni
C
C
Radford
J
J
Dolcetti
R
R
Cavalli
F
F
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D002689:Chlamydia / Q000187:drug effects; D002986:Clinical Trials as Topic; D004318:Doxycycline / Q000494:pharmacology* / Q000627:therapeutic use*; D023381:Endpoint Determination; D005134:Eye Neoplasms / Q000188:drug therapy* / Q000382:microbiology*; D005500:Follow-Up Studies; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy* / Q000382:microbiology*; D011446:Prospective Studies
D000900:Anti-Bacterial Agents; D004318:Doxycycline